Correlation between Electrodiagnostic Findings and Cerebrospinal Fluid Changes in Children with Guillain-Barre syndrome
Iranian Journal of Child Neurology,
Vol. 19 No. 1 (2025),
7 January 2025
,
Page 37-44
https://doi.org/10.22037/ijcn.v19i1.44703
Abstract
Objectives
Guillain-Barré syndrome (GBS) involves the peripheral nervous system developed by infections or immune conditions. Cerebrospinal fluid (CSF) analysis and electrodiagnostic tests are essential diagnostic methods for GBS. However, limited data are available on how the findings from these methods relate to each other. This study aimed to evaluate changes in CSF analysis and electrodiagnostic tests in pediatrics with GBS.
Materials & Methods
The present study retrospectively evaluated electrodiagnostic tests and CSF changes in pediatrics with GBS who were admitted to Tabriz Hospital, Iran, from 2010 to 2020 due to CBS. Patients’ data, including age, gender, CSF analysis, and electrodiagnostic test results, were recorded from the patients’ files. Electrodiagnostic data included pace and amplitude of tibial, median, peroneal, sural, ulnar nerves, nerve conduction velocity (NCV), F-wave, and motor unit action potential (MUAP). The significance level was considered less than 0.05.
Results
The mean age of patients was 4.83±2.72 years, and 54.6% were boys. The most common type of GBS involvement was demyelinating type. No gender differences were found between involved nerves unless the ulnar nerve was significantly more involved in girls (P-value: 0.012). The obtained findings indicated no significant relationship between electrodiagnostic tests and CSF protein (P-value: 0.439).
Conclusion
No association was observed between electrodiagnostic results and CSF changes in pediatrics with GBS.
- cerebrospinal fluid
- electromyography
- Guillain-Barré syndrome
- pediatric
How to Cite
References
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. The Lancet. 2016;388(10045):717-27.
Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123-33.
Lehmann HC, Hughes RA, Kieseier BC, Hartung HP. Recent developments and future directions in Guillain‐Barré syndrome. Journal of the Peripheral Nervous System. 2012;17(s3):57-70.
Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599.
Chanson J-B, Echaniz-Laguna A. Early electrodiagnostic abnormalities in acute inflammatory demyelinating polyneuropathy: a retrospective study of 58 patients. Clinical Neurophysiology. 2014;125(9):1900-5.
Albertí MA, Alentorn A, Martínez‐Yelamos S, et al. Very early electrodiagnostic findings in Guillain‐Barré syndrome. Journal of the Peripheral Nervous System. 2011;16(2):136-42.
Chan YC, Punzalan‐Sotelo AM, Kannan TA, et al. Electrodiagnosis of reversible conduction failure in Guillain–Barré syndrome. Muscle & nerve. 2017;56(5):919-24.
Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137(1):33-43.
Roodbol J, De Wit M, Walgaard C, de Hoog M, Catsman-Berrevoets C, Jacobs B. Recognizing Guillain-Barré syndrome in preschool children. Neurology. 2011;76(9):807-10.
Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, Van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nature Reviews Neurology. 2014;10(8):469-82.
Wu X, Shen D, Li T, et al. Distinct clinical characteristics of pediatric Guillain-Barré syndrome: a comparative study between children and adults in Northeast China. PLoS One. 2016;11(3):e0151611.
Dourado M, Félix R, Da Silva W, Queiroz J, Jeronimo S. Clinical characteristics of Guillain–Barré syndrome in a tropical country: a Brazilian experience. Acta neurologica scandinavica. 2012;125(1):47-53.
Domínguez-Moreno R, Tolosa-Tort P, Patiño-Tamez A, et al. Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos ingresados en instituciones del sistema sanitario mexicano. Rev Neurol. 2014;58(1):4-10.
van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barré syndrome. Neurology. 2013;80(18):1650-4.
Papri N, Islam Z, Leonhard SE, Mohammad QD, Endtz HP, Jacobs BC. Guillain–Barré syndrome in low-income and middle-income countries: challenges and prospects. Nature Reviews Neurology. 2021;17(5):285-96.
Karimzadeh P, Bali MKB, Nasehi MM, Otaghsara SMT, Ghofrani M. Atypical findings of Guillain-Barré syndrome in children. Iranian Journal of Child Neurology. 2012;6(4):17.
Das S, Khan R, Alam S, Chowdhury N, Das P. Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU. Mymensingh medical journal: MMJ. 2018;27(3):631-40.
Kumar P. Mimics and Chameleons in Guillain-Barré Syndrome. Cureus. 2021;13(9).
Wang Y, Sun S, Zhu J, Cui L, Zhang H-L. Biomarkers of Guillain-Barré syndrome: some recent progress, more still to be explored. Mediators of inflammation. 2015;2015.
Pagana K, Pagana T, Pagana T. Mosby's Diagnostic & Laboratory Test Reference. 14th edn St. Louis, Mo: Elsevier. 2019.
DiCapua DB, Lakraj AA, Nowak RJ, Robeson K, Goldstein J, Patwa H. Relationship between cerebrospinal fluid protein levels and electrophysiologic abnormalities in Guillain–Barré syndrome. Journal of Clinical Neuromuscular Disease. 2015;17(2):47-51.
Bourque PR, Brooks J, Warman-Chardon J, Breiner A. Cerebrospinal fluid total protein in Guillain–Barré syndrome variants: correlations with clinical category, severity, and electrophysiology. Journal of Neurology. 2020;267(3):746-51.
- Abstract Viewed: 327 times